Gene editing using CRISPR-Cas9 for the treatment of lung cancer
Main Article Content
- Gene
- CRISPR-Cas9
- Cancer
- treatment
Travis J. Breakthrough of the Year: CRISPR makes the cut. Science Magazine. 2015 http://www.sciencemag.org/news/2015/12/and-science-s-breakthrough-year
Cyranoski D. CRISPR gene-editing tested in a person for the first time. Nature. 2016;539:479–479. DOI: https://doi.org/10.1038/nature.2016.20988
Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. Journal of Bacteriology. 1987;169(12):5429–5433. DOI: https://doi.org/10.1128/jb.169.12.5429-5433.1987
Mojica FJ, Ferrer C, Juez G, Rodríguez-Valera F. Long stretches of short tandem repeats are present in the largest replicons of the Archaea Haloferax mediterranei and Haloferax volcanii and could be involved in replicon partitioning. Mol Microbiol. 1995;17(1):85–93. DOI: https://doi.org/10.1111/j.1365-2958.1995.mmi_17010085.x
Mojica FJ, Díez-Villaseñor C, Soria E, Juez G. Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondri. Mol Microbiol. 2000;36(1):244–246. DOI: https://doi.org/10.1046/j.1365-2958.2000.01838.x
Mojica FJ, Díez-Villaseñor C, García-Martínez J, Soria E. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol. 2005;60(2):174–1826. DOI: https://doi.org/10.1007/s00239-004-0046-3
Horvath P, Barrangou R. CRISPR/Cas, the Immune System of Bacteria and Archaea. Science. 2010;327:167–170. [PubMed] DOI: https://doi.org/10.1126/science.1179555
Marraffini LA, Sontheimer EJ. CRISPR interference RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet. 2010;11(3):181–190. DOI: https://doi.org/10.1038/nrg2749
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821. DOI: https://doi.org/10.1126/science.1225829
Gebler C, Lohoff M, Paszkowski-Rogacz M, Mircetic J, Chakraborty D, Camgoz A, Hamann MV. Inactivation of Cancer Mutations Utilizing CRISPR/Cas9. J Natl Cancer Inst. 2016;109(1):djw183–djw183. DOI: https://doi.org/10.1093/jnci/djw183
Cyranosky D. Chinese scientists to pioneer first human CRISPR trial. Nature. 2016;535:476–477. [PubMed] DOI: https://doi.org/10.1038/nature.2016.20302
National Academies of Sciences Engineering and Medicine . International Summit on Human Gene Editing: A Global Discussion. Washington, DC: The National Academies Press; 2016.
Hirsch F, Lévy Y, Chneiweiss H. CRISPR-Cas9 A European position on genome editing. Nature. 2017;541(7635):30. DOI: https://doi.org/10.1038/541030c
Downloads
- Romel Fabian Gómez, Andres Castillo, Mónica Chávez-Vivas, Characterization of multidrug-resistant Acinetobacter ssp. strains isolated from medical intensive care units in Cali - Colombia. , Colombia Medica: Vol. 48 No. 4 (2017)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use